The Annals of Internal Medicine published an intriguing essay online last week about tight glycemic control in type 2 diabetes. Its authors argue that we’ve got it all wrong: imposing tight controls is only subjecting patients to stresses — related to the complexities and costs of treatment — that make control less likely to succeed. In addition, the supposed benefits of that control haven’t been confirmed by the available evidence. They advocate a backing-off of the current stern limits, which might make visits to clinicians feel less like a visit to the principal’s office. Listen in on a conversation with Dr. Victor Montori, one of the essay’s coauthors.
As always, you are invited to weigh in with your own thoughts. Leave us a piece of your mind at 1-617-440-4374.
